Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Process for preparing [1S-[1-α, 2-α, 3-β(1S*,2R*) 5-β]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3H-1,2,3-triazolo [4,5-d] pyrimidin-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol and to its intermediates

Process for preparing [1S-[1-α, 2-α, 3-β(1S*,2R*) 5-β]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3H-1,2,3-triazolo [4,5-d] pyrimidin-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol and to its intermediates

US Patent 8563755 · Granted Oct 22, 2013

Estimated economic value: $22,570,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical formulation of odevixibat2025
Solution phase synthesis of β-turn peptidomimetic cyclic salts2025
Crystal modifications of odevixibat2024
Pharmaceutical formulation of odevixibat2023
Pharmaceutical formulation of odevixibat2023
Solution phase synthesis of beta-turn peptidomimetic cyclic salts2023
Crystal modifications of odevixibat2022
Combinations of FGFR4 inhibitors and bile acid sequestrants2022
Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic 2021
Crystal modifications of odevixibat2021
Camsylate salt2020
Crystal modifications of elobixibat2019